Skip to main content
. 2023 Apr 3;61(4):2200725. doi: 10.1183/13993003.00725-2022

FIGURE 4.

FIGURE 4

Microbicidal activity of peripheral blood mononuclear cells (PBMCs) against Pseudomonas aeruginosa PAO1 and clinical isolates. a) PBMCs from healthy donors (HD) and people with cystic fibrosis (PWCF) before elexacaftor/tezacaftor/ivacaftor (ETI) therapy (Pre) infected with PAO1. Demographic and clinical characteristics of PWCF are reported in supplementary table S3. t-test. b) PBMCs from PWCF before ETI therapy infected with PAO1 or the clinical isolates AA2 and AA44. One-way ANOVA test with Tukey's multiple comparison test. Scattered dot plot with mean±sem. *: p<0.05.